BRIAN DONNELLY, PhD, RPh
Pharmacology, Forensic Toxicology
New York, USA
Brian Donnelly is Director of the Americas Region, Global Security, Pfizer Inc. in New York, New York. He is currently responsible for coordinating investigations of counterfeit Pfizer pharmaceutical products in the United States, Canada and the Caribbean.
Prior to joining Pfizer, Dr. Donnelly spent 21 years as a Special Agent of the Federal Bureau of Investigation, during which time he was assigned to the FBI Laboratory and the New Haven Division. As a Special Agent Dr. Donnelly was responsible for the investigation of several high profile cases including: the Michael Swango, M.D. medical serial killer investigation, the Yale University bombing investigation and he was the Connecticut case agent for the Amerithrax (anthrax mailings) investigation. He has received several honors and awards from the FBI, the Department of Veterans Affairs and a number of United States Attorneys’ Offices.
Dr. Donnelly received his PhD in the areas of Pharmacology and Toxicology from Saint John’s University, New York in 1990 and is also a registered Pharmacist in the state of New York. He has presented and published extensively in the field of Forensic Toxicology and lectures regularly to medical personnel and law enforcement officers on the subject of Health Care Serial Killers.